Splashy Drug Discovery.
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb, and AstraZeneca are all ramping up the use of AI, but drug discovery ...
Read moreDetails
Tag: #artificail Intelligence
Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with ...
Read moreDetails
BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the ...
Read moreDetails
Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
WASHINGTON, DC - DECEMBER 19: U.S. President Donald Trump speaks during an event in the Roosevelt Room of the White ...
Read moreDetails
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials
Accure to complete required preclinical studies to file IND application for ACT-02 program in 2026 Fonds National de Recherche (FNR) grant will ...
Read moreDetails
In Search Of Game-Changing Technologies At AUTOMA+ 2023
Game-changing industry trends and technologies were discussed at Healthcare Automation and Digitalisation Congress 2023, that was held in Zurich, Switzerland, ...
Read moreDetails
Three reasons AI is not ready to replace radiologists
Artificial intelligence has become a significant force in medicine, and its use in radiology is no exception. AI’s potential to ...
Read moreDetails
